SG11202003879RA - Substituted phenyl sulfonyl phenyl triazole thiones and uses thereof - Google Patents
Substituted phenyl sulfonyl phenyl triazole thiones and uses thereofInfo
- Publication number
- SG11202003879RA SG11202003879RA SG11202003879RA SG11202003879RA SG11202003879RA SG 11202003879R A SG11202003879R A SG 11202003879RA SG 11202003879R A SG11202003879R A SG 11202003879RA SG 11202003879R A SG11202003879R A SG 11202003879RA SG 11202003879R A SG11202003879R A SG 11202003879RA
- Authority
- SG
- Singapore
- Prior art keywords
- phenyl
- substituted phenyl
- thiones
- triazole thiones
- sulfonyl
- Prior art date
Links
- BHAVOZDSGFLVBI-UHFFFAOYSA-N 5-[2-(benzenesulfonyl)phenyl]triazole-4-thione Chemical class C1(=CC=CC=C1)S(=O)(=O)C1=C(C=CC=C1)C=1C(N=NN=1)=S BHAVOZDSGFLVBI-UHFFFAOYSA-N 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/18—Sulfonamides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4196—1,2,4-Triazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
- C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
- C07D243/10—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
- C07D249/10—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D249/12—Oxygen or sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Dispersion Chemistry (AREA)
- Inorganic Chemistry (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Peptides Or Proteins (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762579070P | 2017-10-30 | 2017-10-30 | |
| US201762584630P | 2017-11-10 | 2017-11-10 | |
| PCT/US2018/058050 WO2019089478A1 (en) | 2017-10-30 | 2018-10-29 | Substituted phenyl sulfonyl phenyl triazole thiones and uses thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11202003879RA true SG11202003879RA (en) | 2020-05-28 |
Family
ID=66333645
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11202003879RA SG11202003879RA (en) | 2017-10-30 | 2018-10-29 | Substituted phenyl sulfonyl phenyl triazole thiones and uses thereof |
Country Status (12)
| Country | Link |
|---|---|
| US (4) | US10501423B2 (en) |
| EP (1) | EP3703675A4 (en) |
| JP (2) | JP7277473B2 (en) |
| KR (1) | KR102639231B1 (en) |
| CN (1) | CN111372579B (en) |
| AU (1) | AU2018359224B2 (en) |
| BR (1) | BR112020008727A2 (en) |
| CA (1) | CA3080578A1 (en) |
| IL (1) | IL274010B2 (en) |
| MX (1) | MX2020004202A (en) |
| SG (1) | SG11202003879RA (en) |
| WO (1) | WO2019089478A1 (en) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2019089478A1 (en) | 2017-10-30 | 2019-05-09 | Neuropore Therapies, Inc. | Substituted phenyl sulfonyl phenyl triazole thiones and uses thereof |
| CN112512523A (en) * | 2018-06-20 | 2021-03-16 | 神经孔疗法股份有限公司 | Methods of treating conditions associated with neurodegenerative disorders using inhibitors of OAT3 |
| CN117384029B (en) * | 2023-12-12 | 2024-02-20 | 山东国邦药业有限公司 | Synthesis method of 2,4, 5-trifluoro phenylacetic acid |
Family Cites Families (38)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1476503A (en) | 1973-06-21 | 1977-06-16 | Sterling Drug Inc | 1-arylamino-and 1-arylimino-pyrroles and preparation thereof |
| US4279637A (en) | 1979-06-02 | 1981-07-21 | Velsicol Chemical Corporation | Herbicidal N-substituted 4-imidazolin-2-ones |
| DE3307506A1 (en) | 1983-03-03 | 1984-09-06 | Agfa-Gevaert Ag, 5090 Leverkusen | Photographic recording material with inhibitor precursor compounds |
| US5108486A (en) * | 1990-02-09 | 1992-04-28 | Kanagawa Chemical Laboratory, Ltd. | Herbicidal substituted-phenyl-1,2,4-triazol-5(1H)-thiones and -ones |
| US20040110785A1 (en) | 2001-02-02 | 2004-06-10 | Tao Wang | Composition and antiviral activity of substituted azaindoleoxoacetic piperazine derivatives |
| DE10123586A1 (en) | 2001-05-08 | 2002-11-28 | Schering Ag | New 3,5-diamino-1,2,4-triazole derivatives, are cyclin dependent kinase inhibitors useful for treating e.g. cancer, autoimmune, cardiovascular or neurodegenerative diseases or viral infections |
| US20020183306A1 (en) | 2001-05-30 | 2002-12-05 | Pfizer Inc. | Combination treatment for sleep disorders including sleep apnea |
| RU2223952C2 (en) | 2001-06-04 | 2004-02-20 | Институт физиологически активных веществ РАН | Derivatives of n,s-substituted n'-1-[(hetero)aryl]-n'-[(hetero)aryl]- methylisothioureas or their salts and bases, pharmaceutical composition, method for treatment and method for study of glutamatergic system |
| EP2168576A3 (en) | 2001-09-14 | 2010-05-26 | Shionogi & Co., Ltd. | Tricyclic compounds for treating dyslipidemia and arteriosclerotic diseases |
| SE0301232D0 (en) | 2003-04-25 | 2003-04-25 | Astrazeneca Ab | Novel use |
| JP2009513521A (en) | 2003-07-09 | 2009-04-02 | エフ．ホフマン−ラ ロシュ アーゲー | Thiophenylaminoimidazolines as prostaglandin I2 antagonists |
| DE10344223A1 (en) | 2003-09-24 | 2005-04-21 | Merck Patent Gmbh | New 2-anilino-1,3-benzoxazole derivatives, are inhibitors of kinases, especially tyrosine- or Raf-kinases, useful e.g. for treating solid tumors, angiogenesis, diabetic retinopathy, inflammation or psoriasis |
| US20050228031A1 (en) | 2004-04-13 | 2005-10-13 | Bilodeau Mark T | Tyrosine kinase inhibitors |
| US7008748B1 (en) * | 2004-09-07 | 2006-03-07 | Eastman Kodak Company | Silver salt-toner co-precipitates and imaging materials |
| US7429667B2 (en) | 2005-01-20 | 2008-09-30 | Ardea Biosciences, Inc. | Phenylamino isothiazole carboxamidines as MEK inhibitors |
| US20060217390A1 (en) | 2005-02-24 | 2006-09-28 | Esmir Gunic | Cycloalkl, aryl and heteroaryl amino isothiazoles for the treatment of Hepatitis C virus |
| AU2006244203B2 (en) | 2005-05-09 | 2012-05-03 | Achillion Pharmaceuticals, Inc. | Thiazole compounds and methods of use |
| US20060276464A1 (en) | 2005-05-13 | 2006-12-07 | Wyeth | Diarylsulfone sulfonamides and use thereof |
| JP2009500351A (en) | 2005-07-04 | 2009-01-08 | ドクター レディズ ラボラトリーズ リミテッド | Thiazole derivatives as AMPK activators |
| MY148985A (en) | 2006-03-24 | 2013-06-28 | Array Biopharma Inc | 2-aminopyridine analogs as glucokinase activators |
| ES2358549T3 (en) * | 2006-11-09 | 2011-05-11 | F. Hoffmann-La Roche Ag | ARILSULFONIL, PIRROLIDINS AS INHIBITORS OF 5-HT6. |
| CN101679409B (en) | 2006-12-22 | 2014-11-26 | Astex治疗学有限公司 | Bicyclic heterocyclic derivative compound, pharmaceutical compositions and uses thereof |
| JP5450108B2 (en) | 2007-03-23 | 2014-03-26 | アレイ バイオファーマ、インコーポレイテッド | 2-Aminopyridine analogues as glucokinase activators |
| CA2699718C (en) | 2007-09-21 | 2014-05-27 | Array Biopharma Inc. | Pyridin-2-yl-amino-1, 2, 4-thiadiazole derivatives as glucokinase activators for the treatment of diabetes mellitus |
| WO2009089454A1 (en) | 2008-01-09 | 2009-07-16 | Array Biopharma Inc. | Pyrimidyl cyclopentanes as akt protein kinase inhibitors |
| WO2009117444A1 (en) | 2008-03-17 | 2009-09-24 | Northeastern University | Inhibitors of fatty acid amide hydrolase and monoacylglycerol lipase for modulation of cannabinoid receptors |
| AP2011005859A0 (en) | 2009-02-23 | 2011-10-31 | Glenmark Pharmaceuticals Sa | Humanized antibodies that bind to CD19 and their uses. |
| CN102365310B (en) | 2009-03-27 | 2013-11-20 | 日立化成工业株式会社 | Thermosetting resin composition, and prepreg, insulating film with support, laminate plate, and printed wiring board, each obtained using same |
| UY32582A (en) | 2009-04-28 | 2010-11-30 | Amgen Inc | 3 KINASE PHOSPHINOSITI INHIBITORS AND / OR MAMMAL OBJECTIVE |
| WO2011017350A2 (en) | 2009-08-04 | 2011-02-10 | Amira Pharmaceuticals, Inc. | Compounds as lysophosphatidic acid receptor antagonists |
| US8962631B2 (en) | 2010-05-12 | 2015-02-24 | Vertex Pharmaceuticals Incorporated | Compounds useful as inhibitors of ATR kinase |
| WO2012031196A1 (en) * | 2010-09-03 | 2012-03-08 | Forma Therapeutics, Inc. | 4- { [ ( pyridin- 3 - yl -methyl) aminocarbonyl] amino} benzene - sulfone derivatives as nampt inhibitors for therapy of diseases such as cancer |
| ES2774160T3 (en) | 2012-02-13 | 2020-07-17 | Seattle Childrens Hospital D/B/A Seattle Childrens Res Institute | Bispecific chimeric antigen receptors and therapeutic uses thereof |
| JP6240667B2 (en) | 2012-05-22 | 2017-11-29 | アウトイフオンイ トヘラペウトイクス リミテッド | Triazoles as KV3 inhibitors |
| CA2881472A1 (en) | 2012-08-09 | 2014-02-13 | Neuropore Therapies, Inc. | Aryl-and heteroaryl-substituted benzene derivatives as modulators of pi3-kinase signalling pathways |
| US20140044813A1 (en) * | 2012-08-09 | 2014-02-13 | Kemin Industries, Inc. | Plant Extracts for Improving Cognitive Health and Function |
| TWI654206B (en) | 2013-03-16 | 2019-03-21 | 諾華公司 | Treatment of cancer with a humanized anti-CD19 chimeric antigen receptor |
| WO2019089478A1 (en) * | 2017-10-30 | 2019-05-09 | Neuropore Therapies, Inc. | Substituted phenyl sulfonyl phenyl triazole thiones and uses thereof |
-
2018
- 2018-10-29 WO PCT/US2018/058050 patent/WO2019089478A1/en active Application Filing
- 2018-10-29 CA CA3080578A patent/CA3080578A1/en active Pending
- 2018-10-29 SG SG11202003879RA patent/SG11202003879RA/en unknown
- 2018-10-29 BR BR112020008727-0A patent/BR112020008727A2/en unknown
- 2018-10-29 KR KR1020207015547A patent/KR102639231B1/en active IP Right Grant
- 2018-10-29 AU AU2018359224A patent/AU2018359224B2/en active Active
- 2018-10-29 JP JP2020543258A patent/JP7277473B2/en active Active
- 2018-10-29 MX MX2020004202A patent/MX2020004202A/en unknown
- 2018-10-29 CN CN201880071304.3A patent/CN111372579B/en active Active
- 2018-10-29 EP EP18873686.2A patent/EP3703675A4/en active Pending
-
2019
- 2019-03-27 US US16/366,793 patent/US10501423B2/en active Active
- 2019-10-24 US US16/663,054 patent/US11008294B2/en active Active
-
2020
- 2020-04-16 IL IL274010A patent/IL274010B2/en unknown
-
2021
- 2021-04-06 US US17/223,989 patent/US11708338B2/en active Active
-
2023
- 2023-05-08 JP JP2023076473A patent/JP2023100842A/en active Pending
- 2023-06-05 US US18/206,005 patent/US20230391734A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| AU2018359224B2 (en) | 2023-10-05 |
| US20190292158A1 (en) | 2019-09-26 |
| IL274010B1 (en) | 2023-03-01 |
| JP2023100842A (en) | 2023-07-19 |
| US11008294B2 (en) | 2021-05-18 |
| JP7277473B2 (en) | 2023-05-19 |
| EP3703675A1 (en) | 2020-09-09 |
| US20230391734A1 (en) | 2023-12-07 |
| US20200123116A1 (en) | 2020-04-23 |
| CN111372579B (en) | 2023-08-22 |
| US10501423B2 (en) | 2019-12-10 |
| CA3080578A1 (en) | 2019-05-09 |
| EP3703675A4 (en) | 2021-06-16 |
| AU2018359224A1 (en) | 2020-06-18 |
| IL274010B2 (en) | 2023-07-01 |
| US11708338B2 (en) | 2023-07-25 |
| MX2020004202A (en) | 2020-08-13 |
| US20210300881A1 (en) | 2021-09-30 |
| WO2019089478A1 (en) | 2019-05-09 |
| IL274010A (en) | 2020-05-31 |
| KR102639231B1 (en) | 2024-02-22 |
| JP2021501202A (en) | 2021-01-14 |
| BR112020008727A2 (en) | 2020-10-20 |
| CN111372579A (en) | 2020-07-03 |
| KR20200083545A (en) | 2020-07-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA202001340B (en) | Heterocyclic compound and use thereof | |
| IL273236A (en) | Pyrazolopyrimidinone compounds and uses thereof | |
| SI3319437T1 (en) | Herbicidal composition comprising cinmethylin and pyroxasulfone | |
| PL3319427T3 (en) | Herbicidal composition comprising cinmethylin and dimethenamid | |
| GB201714745D0 (en) | New compounds and uses | |
| GB201714740D0 (en) | New compounds and uses | |
| GB201714734D0 (en) | New compounds and uses | |
| SG11202004877UA (en) | Sulfonamide compounds and use thereof | |
| IL274010A (en) | Substituted phenyl sulfonyl phenyl triazole thiones and uses thereof | |
| IL292488B1 (en) | Pyridinamine-pyridone and pyrimidinamine-pyridone compounds | |
| IL277502A (en) | Compounds and uses thereof | |
| IL279483A (en) | Cyanotriazole compounds and uses thereof | |
| GB201714736D0 (en) | New compounds and uses | |
| GB201712110D0 (en) | New compounds and uses | |
| GB201700404D0 (en) | Compounds and composistions | |
| IL292482B2 (en) | Azaindolylpyridone and diazaindolylpyridone compounds | |
| IL262601A (en) | Point density illustration | |
| GB2562083B (en) | Fungicidal composition and use thereof | |
| GB201718419D0 (en) | Wardrobe Lab | |
| GB201714743D0 (en) | New compounds and uses | |
| LT3319437T (en) | Herbicidal composition comprising cinmethylin and pyroxasulfone | |
| HUE044159T2 (en) | Herbicidal composition comprising cinmethylin and dimethenamid |